Covered recipient · General Payments record
TRACY COLLINS
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$7,292.55
- Reported across 196 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $434.83 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $113.53 | 4 |
| SHIELD THERAPEUTICS INC | $89.91 | 2 |
| Novo Nordisk AS | $64.68 | 2 |
| PFIZER INC. | $61.48 | 3 |
| MAYNE PHARMA COMMERCIAL LLC | $31.53 | 2 |
| Organon LLC | $31.33 | 2 |
| Innovation Technologies Inc | $24.24 | 1 |
| Exeltis, USA Inc. | $18.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $30.69 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139328600 | CMS |
| Astellas Pharma US Inc | $16.80 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139275206 | CMS |
| Astellas Pharma US Inc | $31.60 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139405421 | CMS |
| Astellas Pharma US Inc | $34.44 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139405429 | CMS |
| Exeltis, USA Inc. | $18.13 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149990959 | CMS |
| Innovation Technologies Inc | $24.24 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130819939 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $24.79 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154714281 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $6.74 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154714283 | CMS |
| Novo Nordisk Inc | $41.85 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096739513 | CMS |
| Novo Nordisk Inc | $22.83 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097570263 | CMS |
| Organon Llc | $26.52 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136313107 | CMS |
| Organon Llc | $4.81 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136257615 | CMS |
| PFIZER INC. | $18.10 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131588507 | CMS |
| PFIZER INC. | $21.61 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131588511 | CMS |
| PFIZER INC. | $21.77 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131588515 | CMS |
| SHIELD THERAPEUTICS INC | $56.55 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150138003 | CMS |
| SHIELD THERAPEUTICS INC | $33.36 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150146731 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.